Delivery Order SPE2DB22D2007-SPE2DB24FJ4RS

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,437.17 firm fixed-price delivery order is for 4563844946 LOTREL 10-20 MG CAPSULE 100S, with a period of performance ending on March 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency (DLA) awarded a $10,580.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of LOTREL 10-20 MG CAPSULE 100S. This contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,896.27 Firm Fixed Price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,116.40 firm fixed-price contract is to provide LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication, with a period of performance through November 28, 2023. The contract was not set aside for any specific business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,843.42 firm fixed-price contract is for the supply of LOTREL 10-20 mg capsules, a prescription medication. The award has an ultimate completion date of August 29, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts with federal agencies, including a $999,999,999 IDC with DLA Troop Support...
This federal contract award, valued at $10,380.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,966,794 units of the medication LOTREL 10-40 MG CAPSULE 100S, with a performance period ending on April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $13,275.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is a delivery order (SPE2DB24D3014|SPE2DB24FKSCY) valued at $14,829.18 for the supply of LOTREL 10-20 mg capsules to the Defense Logistics Agency (DLA). The award has an ultimate completion date of September 5, 2024 and is a firm fixed-price contract. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medications and medical supplies to various federal agencies and healthcare...
This federal contract award, valued at $33,506.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of 4,556,447,587 units of the cardiovascular medication Lotrel 10-20 mg capsules in 100-count bottles. This is a firm-fixed-price delivery order contract, with a completion date of March 4, 2022. The contract was awarded on an unrestricted, full and open competition basis, with no set-aside...
This federal contract award is for the delivery of Lotrel 10-40 mg capsules, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,700.85 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 6, 2023. The contract has a completion date of February 7, 2023 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ4RS
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,890.68 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4,565,295,981 units of the drug Lotrel 10-20 mg capsules in 100-count packages. The contract has a period of performance through July 31, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, for providing a range of pharmaceutical and medical supplies to support military treatment programs, federal healthcare, and law enforcement. This contract award does not have a set-aside designation.

Generated 10/29/24, 9:02 AM